Clinical Trial: Neoadjuvant Complete Response Customized Treatment Approach for Definitive Management of Breast Cancer

U.S., Oct. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07217990) titled 'Neoadjuvant Complete Response Customized Treatment Approach for Definitive Management of Breast Cancer' on Oct. 15.

Brief Summary: This study will evaluate the efficacy and non-inferiority of a non-surgical approach for the treatment of patients with locally advanced breast cancer.

Study Start Date: Dec. 15

Study Type: INTERVENTIONAL

Condition: Breast Cancer HER2-positive Breast Cancer Triple Negative Breast Cancer

Intervention: DRUG: Neoadjuvant Chemotherapy

Participants will receive standard of care neoadjuvant chemotherapy

RADIATION: Radiation Therapy

Radiotherapy simulation parameters will be at the discretion of the tr...